Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinomaOA
Objective:To investigate the safety,efficacy,and prognostic factors of hepatic arterial infusion chemotherapy(HAIC)with raltitrexed and oxaliplatin post-transarterial chemoembolization(TACE)for unresectable hepatocellular car…查看全部>>
Baojiang Liu;Xu Zhu;Song Gao;Jianhai Guo;Xiaodong Wang;Guang Cao;Linzhong Zhu;Peng Liu;Haifeng Xu;Hui Chen;Xin Zhang;Shaoxing Liu;Fuxin Kou
Key Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,ChinaKey Laboratory of Carcinogenesis and Translational Research,Department of Interventional Therapy,Peking University Cancer Hospital&Institute,Beijing,100142,China
医药卫生
Hepatocellular carcinomaTranscatheter arterial chemoembolization(TACE)Hepatic arterial infusion chemotherapy(HAIC)OxaliplatinRaltitrexed
《介入医学杂志(英文)》 2019 (2)
P.91-96,6
评论